AEterna Zentaris Inc (AEZS)
7.96
+0.16
(+2.05%)
USD |
NASDAQ |
May 09, 11:21
AEterna Zentaris Free Cash Flow (Quarterly): -5.385M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.385M |
| September 30, 2023 | -3.393M |
| June 30, 2023 | -4.296M |
| March 31, 2023 | -4.063M |
| December 31, 2022 | -3.378M |
| September 30, 2022 | -3.954M |
| June 30, 2022 | -4.892M |
| March 31, 2022 | -1.467M |
| December 31, 2021 | -2.537M |
| September 30, 2021 | -1.493M |
| June 30, 2021 | -3.638M |
| March 31, 2021 | -1.552M |
| December 31, 2020 | 2.518M |
| September 30, 2020 | -1.793M |
| June 30, 2020 | -2.41M |
| March 31, 2020 | -2.444M |
| December 31, 2019 | -2.954M |
| September 30, 2019 | -2.595M |
| June 30, 2019 | -2.17M |
| March 31, 2019 | -3.006M |
| December 31, 2018 | -2.679M |
| September 30, 2018 | -2.436M |
| June 30, 2018 | -4.777M |
| March 31, 2018 | 16.72M |
| December 31, 2017 | -4.527M |
| Date | Value |
|---|---|
| September 30, 2017 | -5.534M |
| June 30, 2017 | -5.894M |
| March 31, 2017 | -6.962M |
| December 31, 2016 | -8.14M |
| September 30, 2016 | -5.712M |
| June 30, 2016 | -6.371M |
| March 31, 2016 | -8.853M |
| December 31, 2015 | -8.412M |
| September 30, 2015 | -7.15M |
| June 30, 2015 | -8.123M |
| March 31, 2015 | -10.18M |
| December 31, 2014 | -8.653M |
| September 30, 2014 | -6.567M |
| June 30, 2014 | -6.409M |
| March 31, 2014 | -9.58M |
| December 31, 2013 | 3.417M |
| September 30, 2013 | -8.393M |
| June 30, 2013 | -9.189M |
| March 31, 2013 | -5.904M |
| December 31, 2012 | -8.876M |
| September 30, 2012 | -7.191M |
| June 30, 2012 | -6.582M |
| March 31, 2012 | -8.438M |
| December 31, 2011 | -8.691M |
| September 30, 2011 | -10.50M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.385M
Minimum
Dec 2023
2.518M
Maximum
Dec 2020
-2.731M
Average
-2.595M
Median
Sep 2019
Free Cash Flow (Quarterly) Benchmarks
| Acasti Pharma Inc | -1.892M |
| Aurinia Pharmaceuticals Inc | 14.25M |
| Edesa Biotech Inc | -1.406M |
| Lexaria Bioscience Corp | -0.6766M |
| Xenon Pharmaceuticals Inc | -35.54M |